Inc reported its fourth-quarter 2024 earnings, revealing a shortfall in earnings per share (EPS) compared to analyst expectations. The company posted an EPS of $0.78, falling short of the forecasted ...
Wednesday closed up +0.39%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.71%, and the Nasdaq 100 Index ($IUXX) ...
Reports Q4 revenue $68.11M vs. $42.4M last year. “In Q4, we surpassed revenue expectations highlighting our market diversification, and entered ...
Adjusted EBITDA for 2025 is projected to range between $670 million and $690 million, with adjusted EPS expected between $1.61 and $1.68. The company assumes a stable pricing environment but flagged ...
Reports Q4 revenue $34.79M, consensus $34.11M. Commenting on the results, Art Zeile, President and CEO of DHI Group (DHX), said: “We have ...
Analysis of Spotify's impressive Q4 earnings, showing growth in subscribers, revenue, and a profitable year ahead. Click here ...
Palantir Technologies (NYSE:PLTR) has been a lightning rod for investor debate over the past few quarters as the stock has ...
The New York Times Co. reported strong Q4 earnings with notable digital growth and resilient multi-revenue streams.
T. Rowe Price Group noted improvements in earnings year over year, yet missed analysts' expectations for both EPS and revenue due to sizable net client outflows.
Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set of results.
Pfizer Inc (PFE) reports robust financial performance with significant revenue growth and strategic progress in oncology and ...